Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

被引：0
|
作者：
Maya-Miles, Douglas [1 ,2 ]
Gallego-Duran, Rocio [1 ,2 ]
Munoz Hernandez, Rocio [1 ,2 ]
Rojas, Angela [1 ,2 ]
Gil-Gomez, Antonio [1 ,2 ]
Montero-Vallejo, Rocio [1 ,2 ]
Gato, Sheila [1 ,2 ]
Giraldez-Jimenez, Maria [1 ,2 ]
Ampuero, Javier [1 ,2 ]
Romero Gomez, Manuel [1 ,2 ]
机构：
[1] Univ Seville, Hosp Univ Virgen Rocio, Seliver Grp, Inst Biomed Sevilla IBiS,CSIC, Seville, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT014
引用
收藏
页码：S660 / S660
页数：1
相关论文
共 50 条
  • [1] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [2] The Serum Biomarkers of Cardiovascular Disease Are Elevated in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) With Advanced Fibrosis and Histologically-Proven Non-alcoholic Steatohepatitis (NASH)
    Elsheikh, Elzafir
    Tran, Henry A.
    Karrar, Azza
    Estep, Michael
    Felix, Sean C.
    Jeffers, Thomas
    Younoszai, Zahra
    Racila, Andrei
    Fang, Yun
    Elsheikh, Munkhzul
    Lam, Brian P.
    Abdul-Al, Hala
    Goodman, Zachary
    Gerber, Lynn
    Younossi, Zobair M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S538 - S539
  • [3] Predictive Value of ALT for Diagnosing Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
    Verma, Siddharth
    Sharma, Prashant
    Hart, John
    Mohanty, Smruti R.
    GASTROENTEROLOGY, 2012, 142 (05) : S1019 - S1020
  • [4] Independent Predictors of Non-alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in a Large Cohort of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Fang, Yun
    Rafiq, Nila
    Afendy, Mariam
    Younossi, Youssef
    Lam, Brian
    Goodman, Zachary
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S120 - S120
  • [5] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miele, Luca
    Forgione, Alessandra
    Gasbarrini, Giovanni
    Grieco, Antonio
    TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
  • [6] Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Verma, Siddharth
    Jensen, Donald
    Hart, John
    Mohanty, Smruti R.
    LIVER INTERNATIONAL, 2013, 33 (09) : 1398 - 1405
  • [7] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    DIABETES, 2012, 61 : A265 - A266
  • [8] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [9] Predictors of Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
    Pagadala, Mangesh
    Zein, Claudia O.
    McCullough, Arthur J.
    CLINICS IN LIVER DISEASE, 2009, 13 (04) : 591 - +
  • [10] Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
    Gallego-Duran, Rocio
    Cerro-Salido, Pablo
    Gomez-Gonzalez, Emilio
    Jesus Pareja, Maria
    Ampuero, Javier
    Carmen Rico, Maria
    Aznar, Rafael
    Vilar-Gomez, Eduardo
    Bugianesi, Elisabetta
    Crespo, Javier
    Jose Gonzalez-Sanchez, Francisco
    Aparcero, Reyes
    Moreno, Inmaculada
    Soto, Susana
    Teresa Arias-Loste, Maria
    Abad, Javier
    Ranchal, Isidora
    Jesus Andrade, Raul
    Luis Calleja, Jose
    Pastrana, Miguel
    Lo Iacono, Oreste
    Romero-Gomez, Manuel
    SCIENTIFIC REPORTS, 2016, 6
12345